Latest Beverages News

XRF Scientific Limited reported a robust half-year performance ending December 2024, with revenue edging up 0.3% to $28.7 million and net profit after tax surging 11.8% to $5.0 million, driven by strong consumables sales and international growth.

Althea Group Holdings has raised $4 million through a share and loan note placement to boost its THC beverage production and infrastructure across North America, targeting rapid growth in the U.S. and Canada.

Sprintex has completed commissioning of its compressor systems with Mest Water and is poised to receive a €3.8 million purchase order, marking a pivotal step in expanding its environmental technology footprint across the EU.

Althea Group Holdings has sharply downgraded its FY25 financial guidance, citing significant challenges in its medicinal cannabis division and the strategic withdrawal from a vape product initiative. Despite the setback, the company highlights ongoing growth in its recreational cannabis operations and a strategic refocus on capital efficiency.

Orora reports a 24.6% rise in underlying EBIT to $120.8 million for H1 FY25, driven by the Saverglass acquisition and portfolio simplification, while navigating operational challenges and market headwinds.

Orora Limited reported a robust first half of FY25 with underlying EBIT rising 24.6%, driven by strategic portfolio simplification and organic growth investments despite challenges in the Australian wine market.

Biome Australia has partnered with the Food and Beverage Accelerator (FaBA) to jointly develop its promising BMB18 probiotic strain, leveraging $50 million in Australian government funding while retaining full IP ownership.

Amcor delivered steady volume and earnings growth in Q2 FY25, reaffirming its full-year guidance while progressing its transformative merger with Berry Global.

Althea Group Holdings reported a 20% increase in customer receipts to $9.01 million for Q2 FY25, while addressing governance lapses and reviewing its FY25 guidance. The company is advancing operational improvements and cost savings as it prepares for a pivotal Federal Court hearing.

Codeifai Limited reports a sharp 59% reduction in quarterly cash burn alongside a 48% rise in cash receipts, driven by its new ConnectQR SaaS platform and a strategic review of its Material Science division.

EVE Health Group has completed the sale of its Robyndale tea tree property and relaunched its postbiotic concentrate range, signaling a strategic shift towards innovation and growth in the Australian market.

Universal Biosensors is expanding its handheld testing portfolio with the upcoming AQUASCOUT water sensor and growing sales of its FDA-approved Xprecia Prime blood coagulation device, targeting multi-billion-dollar markets.